William Enright insider trades
Open-market stock purchases and sales by William Enright, Chief Executive Officer at Barinthus Biotherapeutics plc., from SEC Form 4 filings since May 4, 2017.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Sold (not open market) | — |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Sold (not open market) | — |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Sold (not open market) | — |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Sold (not open market) | — |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Sold (not open market) | — |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Sold (not open market) | — |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Sold (not open market) | — |
| Jun 11, 2026 | BFRG BullFrog AI Holdings, Inc | Bought (not open market) | — |
Companies traded
- BRNS Barinthus Biotherapeutics plc.: other filings, last Sep 9, 2026
- BFRG BullFrog AI Holdings, Inc: other filings, last Jun 11, 2026
- BFRG,BFRGW BullFrog AI Holdings, Inc: 1 buy, last Jun 14, 2023
- VACC Vaccitech plc: 1 sale, last Mar 27, 2023
- ALT Altimmune, Inc: 1 buy, last May 25, 2018
- NASDAQ:ALT Altimmune, Inc: other filings, last May 4, 2017